Dr. Rahul Kushwah reports

PREDICTMEDIX AI EXPANDS INTO MOBILE DIAGNOSTICS WITH NEW AI-DRIVEN DIABETES SCREENING PLATFORM

Predictmedix AI Inc. is expanding into the direct-to-consumer market with a mobile solution designed to deliver rapid, non-invasive diabetic screening -- with India identified as the initial launchpad for this transformative initiative. Leveraging the company's proprietary AI technology, the platform is intended to empower millions with instant access to diabetic risk assessments using only a smart phone, eliminating the need for blood draws, lab visits or clinical infrastructure.

By combining advanced facial and biometric analysis with seamless smart phone delivery, the solution brings accessible, affordable and scalable diabetic screening to some of the most underserved populations across India. This milestone represents a significant step in Predictmedix AI's broader vision to reshape global health care delivery and accelerate the adoption of AI-enabled, mass-scale preventive health solutions.

"We are addressing a critical gap in healthcare access with a cutting-edge solution that empowers individuals to take control of their health using the device they already own -- their mobile phone," said Dr. Rahul Kushwah, chief operating officer of Predictmedix AI. "India has over 100 million diabetics and a significant number remain undiagnosed. Our app is designed to bridge that diagnostic divide."

Key features:

• Instant diabetic risk scoring via smart phone;
• AI-driven facial and biometric analysis based on Predictmedix's proven non-invasive screening platform;
• User-friendly design with multilingual support for broad accessibility;
• Secure, privacy-compliant data handling, in line with India's Digital Personal Data Protection (DPDP) Act.

Strategic significance

India's diabetes epidemic is accelerating, with estimates projecting nearly one in three adults to be diabetic or prediabetic by 2045. Simultaneously, smart phone adoption now exceeds 1.1 billion users -- a convergence that creates a once-in-a-generation opportunity for mobile-first, AI-powered health solutions.

The company's platform is uniquely positioned to:

• Capture significant market share in a high-need, high-growth region;
• Generate recurring revenue streams through direct-to-consumer and B2B (business-to-business) channels;
• Align with public health priorities of governments, NGOs (non-government organizations) and large employers;
• Scale globally with minimal marginal cost, leveraging cloud-based delivery.

Details of the company's recent product validations, pilot programs and strategic partnerships can be found in earlier press releases available at the company's website.

About Predictmedix AI Inc.

Predictmedix AI is an emerging provider of rapid health screening and remote patient care solutions globally. The company's safe entry stations -- powered by a proprietary artificial intelligence (AI) -- use multispectral cameras to analyze physiological data patterns and predict a variety of health issues including 19 physiological vital parameters, impairment by drugs or alcohol, fatigue, or various mental illnesses. Predictmedix AI's proprietary remote patient care platform empowers medical professionals with a suite of AI-powered tools to improve patient health outcomes.

We seek Safe Harbor.